• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550400-23
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 05/27/2021
Event Type  Death  
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the lot number was not provided.The investigation was unable to determine a conclusive cause for the reported difficult wall apposition.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of thrombosis and death are listed in the xience sierra, everolimus eluting coronary stent system instructions for use as known patient effects of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.Medical affairs reviewed the reported information.The reviewer concluded that based on the limited information provided, it can be stated that the cause of death was due to acute thrombosis secondary to procedural complication and not directly related to both xience sierra stents.The stents were not fully expanded and not well apposed to the vessel wall plus the reported non-compliance to dapt all could have contributed to the development of thrombus.Xience sierra stents did not cause or contribute to this patient¿s death.The additional device referenced is filed under a separate medwatch report number - 2024168-2021-05082-00.
 
Event Description
It was reported that the procedure was performed to treat an in-stent restenosis in the left anterior descending (lad).A 3.0 x 23 mm xience sierra stent delivery system (sds) was advanced to the target lesion and the stent was implanted.However, it was noted that plaque shift had occurred which caused an obstruction to the septal and diagonal branches.The physician was able to use a guide wire to open up the branches.The procedure was completed.When the patient was taken off the table, the patient coded (cardiopulmonary arrest).Cardiopulmonary resuscitation (cpr) defibrillator and intra-aortic balloon pump therapy were used the patient was put back on the table and stent thrombosis was noted.Aspiration was performed to treat the thrombus.Additionally, a 4.0 x 23 mm xience sierra stent was implanted in lad to the left main artery.The patient was taken to the recovery room and died shortly after on (b)(6) 2021 due to acute thrombosis.In the physician's opinion, the xience sierra stents did not cause or contribute to the death, but the stents were suspected to be not fully expanded.Additionally, the patient had a history of being not compliant with the dual antiplatelet drug therapy (dapt).No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P031)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key12189182
MDR Text Key262214839
Report Number2024168-2021-06172
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227516
UDI-Public08717648227516
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 07/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1550400-23
Device Catalogue Number1550400-23
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/24/2021
Initial Date FDA Received07/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
XIENCE SIERRA
Patient Outcome(s) Death;
Patient Age78 YR
Patient Weight64
-
-